Seres Therapeutics Inc (MCRB)
1.145
+0.04
(+3.15%)
USD |
NASDAQ |
May 03, 16:00
1.16
+0.02
(+1.31%)
After-Hours: 20:00
Seres Therapeutics Revenue (Quarterly): 0.064M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.064M |
| September 30, 2023 | 0.31M |
| June 30, 2023 | 126.47M |
| March 31, 2023 | -0.522M |
| December 31, 2022 | 0.975M |
| September 30, 2022 | 3.444M |
| June 30, 2022 | 1.216M |
| March 31, 2022 | 1.493M |
| December 31, 2021 | 8.291M |
| September 30, 2021 | 126.72M |
| June 30, 2021 | 5.263M |
| March 31, 2021 | 5.718M |
| December 31, 2020 | 17.56M |
| September 30, 2020 | 1.417M |
| June 30, 2020 | 6.045M |
| March 31, 2020 | 8.189M |
| Date | Value |
|---|---|
| December 31, 2019 | 7.622M |
| September 30, 2019 | 7.031M |
| June 30, 2019 | 12.53M |
| March 31, 2019 | 7.321M |
| December 31, 2018 | 10.63M |
| September 30, 2018 | 9.055M |
| June 30, 2018 | 4.612M |
| March 31, 2018 | 3.971M |
| December 31, 2017 | 3.056M |
| September 30, 2017 | 23.02M |
| June 30, 2017 | 3.014M |
| March 31, 2017 | 3.015M |
| December 31, 2016 | 3.036M |
| September 30, 2016 | 13.02M |
| June 30, 2016 | 3.004M |
| March 31, 2016 | 2.71M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-0.522M
Minimum
Mar 2023
126.72M
Maximum
Sep 2021
17.89M
Average
5.718M
Median
Mar 2021
Revenue (Quarterly) Benchmarks
| Integra Lifesciences Holdings Corp | 397.04M |
| Nuwellis Inc | 2.551M |
| Axogen Inc | 42.92M |
| Axsome Therapeutics Inc | 71.53M |
| 908 Devices Inc | 14.35M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -41.25M |
| Total Expenses (Quarterly) | 39.59M |
| EPS Diluted (Quarterly) | -0.32 |
| Enterprise Value | 141.20M |
| Profit Margin (Quarterly) | -64.45K% |
| Earnings Yield | -78.60% |
| Normalized Earnings Yield | -78.60 |